| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/22/2008 | US20080119450 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119407 Vitamin D Receptor Modulators |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080118592 treating pruritis associated with psychosis by local administration; skin itching, hallucinations obsessive compulsive disorders treated by low dose, intramuscular administration of botulinum toxin |
| 05/22/2008 | US20080118583 plant extracts with Vitamin B1 and Vitamin E together, for alleviate the neurodegenerative disease, with minimal side effects |
| 05/22/2008 | US20080118577 Composition For Regulating Autonomic Nerves And Method For Using The Same |
| 05/22/2008 | US20080118571 Modified release analgesic suspensions |
| 05/22/2008 | US20080118558 2-Isopropyl-5-methyl-cyclohexanecarboxylic acid [2'-hydroxy-2'-(3''-hydroxy-phenyl)-ethyl]-N-methyl-amide; topical analgesics and antipruritic and antitussive agents for disorders caused by kidney failure or cholestatic jaundice |
| 05/22/2008 | US20080118556 Tablets or capsules with an outer controlled release layer preferably comprising methacrylate-based Eudragits"; one inner portion is quick release and the other portion is sustained release |
| 05/22/2008 | US20080118534 Low dose, intramuscular injection of botulinum toxin |
| 05/22/2008 | US20080118520 Variable heavy chains; immunoglobulins; neurodegenerative diseases |
| 05/22/2008 | US20080118499 Using concentration of golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) as diagnostic indicator of beta-site amyloid precursor protein cleaving enzyme (BACE) activity and prognostic tool for detection of cardiovascular, nervous sytem and cell proliferative disorders |
| 05/22/2008 | US20080118480 Methods and Compositions for Directing Migration of Neural Progenitor Cells |
| 05/22/2008 | US20080118479 Cell Lines |
| 05/22/2008 | US20080118442 Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation |
| 05/22/2008 | US20080118434 Genes Commonly Regulated by Different Classes of Antidepressants |
| 05/22/2008 | CA2669853A1 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 05/22/2008 | CA2669800A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668744A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | CA2668693A1 Therapeutic uses of tim-3 modulators |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2667128A1 Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent |
| 05/22/2008 | CA2666903A1 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1922320A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 05/21/2008 | EP1922083A2 Truncated memapsin 2 for use for treating alzheimer's disease |
| 05/21/2008 | EP1922066A2 Topiramate compositions for treatment of headache |
| 05/21/2008 | EP1922063A1 Method of treating pain in patients |
| 05/21/2008 | EP1768948B1 Substituted amino compounds as 5-ht/na uptake inhibitors |
| 05/21/2008 | EP1635820B1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
| 05/21/2008 | EP1603893B1 Ep4 receptor antagonists |
| 05/21/2008 | EP1562958B1 N-sulfonylaminothiazole |
| 05/21/2008 | EP1456206B1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP1140088B1 Controlled/modified release oral methylphenidate formulations |
| 05/21/2008 | DE20221841U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl |
| 05/21/2008 | CN101184753A Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 05/21/2008 | CN101184735A Crystalline form of benzazepinium maleate derivative |
| 05/21/2008 | CN101184729A Inhibitors of cytosolic phospholipase a2 |
| 05/21/2008 | CN101184725A N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 05/21/2008 | CN101184493A Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 05/21/2008 | CN101184492A Method for the treatment of noise phobia in companion animals |
| 05/21/2008 | CN101182317A Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 05/21/2008 | CN101181622A Method for preparing water extraction of white vein ointment |
| 05/21/2008 | CN101181614A Medicament for curing podosoma numbness caused by cerebrovascular disease |
| 05/21/2008 | CN101181608A Medicine for giving up drug |
| 05/21/2008 | CN101181607A Fragrant cream for giving up smoke |
| 05/21/2008 | CN101181603A Facial palsy correcting paste and preparation method thereof |
| 05/21/2008 | CN101181592A Chinese medicine for curing intractable headache and sick headache |
| 05/21/2008 | CN101181577A Lavender strip containing natural aromatic plant |
| 05/21/2008 | CN101181537A Quick-effective drug rehabilitation capsule |
| 05/21/2008 | CN101181532A Chinese herbal medicine for curing anhypnia |
| 05/21/2008 | CN101181493A Medicine for treating epilepsy |
| 05/21/2008 | CN101181492A Chinese medicine prescription for aypnia as well as manufacturing method |
| 05/21/2008 | CN101181486A Depression treating medicine and preparation method thereof |
| 05/21/2008 | CN101181483A Chinese patent drug for curing cataptosis and hemiparalysis sequela |
| 05/21/2008 | CN101181448A Oral administration proprietary Chinese medicine for curing facial palsy |
| 05/21/2008 | CN101181447A Yizhibuwang powder |
| 05/21/2008 | CN101181428A Compound essential oil for curing headache and neurotic headache as well as method of producing the same |
| 05/21/2008 | CN101181425A Chinese medicine externally used liniment |
| 05/21/2008 | CN101181398A Sachet with appreciable stimulating action |
| 05/21/2008 | CN101181393A Chinese medicine preparation for curing common cold and producing method thereof |
| 05/21/2008 | CN101181383A Medicine composition for treating apoplexy as well as preparation method |
| 05/21/2008 | CN101181382A Chinese medicine emplastrum for soothing the mind to sleep |
| 05/21/2008 | CN101181359A Rheumatism-treating medical liquor |
| 05/21/2008 | CN101181354A Fructus schizandrae chemical composition group extract and preparation technique |
| 05/21/2008 | CN101181348A Chinese medicine prescription for applying headache and method for preparing the same |
| 05/21/2008 | CN101181323A Panax as well as preparation method and application of extract thereof |
| 05/21/2008 | CN101181315A New purpose of Yulangsan polysaccharide |
| 05/21/2008 | CN101181305A Extract of acaleph toxin as well as preparation method and usage thereof |
| 05/21/2008 | CN101181285A Application of astragaloside IV in the preparation of medicament for curing nervus retrogression disease |
| 05/21/2008 | CN101181267A Zolmitriptan tongue tablet |
| 05/21/2008 | CN101181241A Fentanyl composition for nasal administration |
| 05/21/2008 | CN101181057A Orally taken medicinal food for curing neurasthenia |
| 05/21/2008 | CN101181054A Health food for improving dormancy |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100388947C Chinese for drug abstinence and its preparation process |
| 05/21/2008 | CN100388936C Bolus for treating collateral and gynecological disease |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |